Top

Gepubliceerd in:

2012 | OriginalPaper | Hoofdstuk

25. Acute Catheter-Based Mechanical Circulatory Support

Auteurs : Gladwin S. Das, MD, Ganesh Raveendran, MD, Jason C. Schultz, MD

Uitgeverij: Springer US

Abstract

Procedural and technology-based advances in circulatory support have enabled an increased number of patients to receive percutaneous coronary intervention (PCI). Without these advances, many patients would not have been considered for the procedure because of their elevated risk for complications. This chapter describes transcatheter-based circulatory support devices in clinical use today as well as data that support their usage and suggested protocols.

vorige hoofdstuk Refractory Angina

volgende hoofdstuk Surgical Mechanical Circulatory Support

Hurst JW. The first coronary angioplasty as described by Andreas Gruentzig. Am J Cardiol. 1986;57:185–6.PubMedCrossRef

Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:263.PubMedCrossRef

Gruntzig AR, Senning A, Siegenthlaer WE. Nonoperative dilatation of coronary-artery stenosis. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61–8.PubMedCrossRef

Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:135–40.

Talpins NL, Kripke DC, Goetz RH. Counterpulsation and intraaortic balloon pumping in cardiogenic shock. Circ Dynam Arch Surg. 1968;97:991–9.

Scheidt S, Wilner G, Mueller H, et al. Intraortic balloon pumping in cardiogenic shock. Report of a cooperative clinical trial. N Engl J Med. 1973;288:979–84.PubMedCrossRef

Willerson JT, Curry GC, Watson JT, et al. Intra-aortic balloon counterpulsation in patients with cardiogenic shock, medically refractory heart failure, and/or recurrent ventricular tachycardia. Am J Med. 1975;58:183–91.PubMedCrossRef

DeWood MA, Notske RN, Hensley GR, et al. Intra-aortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation. 1980;61:1105–12.PubMedCrossRef

Nanas JN, Moulopoulos SD. Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects. Cardiology. 1994;84:156–67.PubMedCrossRef

10.

Kern MJ. Cardiac support devices: intra-aortic balloon pump. In: The cardiac catheterization handbook. 4th ed. St. Louis: Mosby; 2003. p. 479–94.

11.

Shawl FA, Domanski MJ, Hernandez TJ, et al. Emergency percutaneous cardiopulmonary bypass with cardiogenic shock from acute myocardial infarction. Am J Cardiol. 1989;64:967–70.PubMedCrossRef

12.

Vogel RA, Shawl FA, Tommaso CL, et al. Initial report of the national registry of elective cardiopulmonary bypass SUPPORTED coronary angioplasty. J Am Coll Cardiol. 1990;15:23–9.PubMedCrossRef

13.

Shawl FA, Domanski MJ, Punja S. Percutaneous cardiopulmonary bypass support in high risk patients undergoing percutaneous transluminal coronary angioplasty. Am J Cardiol. 1989;64:1258–63.PubMedCrossRef

14.

Lincoff AM, Popma JJ, Ellis SG, et al. Abrupt vessel closure complicating coronary angioplasty. Clinical, angiographic, and therapeutic profile. J Am Coll Cardiol. 1992;19:926–35.PubMedCrossRef

15.

Bauters C, Van Belle E, Lablanche JM et al. Predictive factors of primary success after coronary angioplasty. Arch Mal Coeur Vaiss. 1994 Feb; 87(2); 193–9

16.

Meier B. Percutaneous coronary intervention. In: Topel EJ, editor. Textbook of cardiovascular medicine. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 1665–76.

17.

Brigouri C, Sardis C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003;145:700–7.CrossRef

18.

Mishra S, Chu WC, Torguson R, et al. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006;98:608–12.PubMedCrossRef

19.

Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997;29:1459–67.PubMedCrossRef

20.

Mackensie DJ, Wagner WH, Kulber DA, et al. Vascular complications of the intra-aortic balloon pump. Am J Surg. 1992;164:517–21.CrossRef

21.

Cook L, Pillar B, McCord G, et al. Intra-aortic balloon pump complications: a five-year retrospective study of 283 patients. Heart Lung. 1999;28:195–202.PubMedCrossRef

22.

Cohen M, Dawson MS, Kopistansky C, et al. Sex and other predictors of intra-aortic balloon conterpulsation-related complications: prospective study of 1119 consecutive patients. Am Heart J. 2000;139:282–7.PubMed

23.

Meisel S, Shocat M, Sheikha SA, et al. Utilization of low profile intraaortic balloon catheters inserted by the sheathless technique in acute cardiac patients: clinical efficacy with a very low complication rate. Clin Cardiol. 2004;27:600–4.PubMedCrossRef

24.

Vogel RA, Tommaso CL, Gundry SR. Initial experience with coronary angioplasty and aortic valvuloplasty using elective semi-percutaneous cardiopulmonary support. Am J Cardiol. 1988;62:811–3.PubMedCrossRef

25.

Phillips SJ, Zeff RH, Kongtahworn C, et al. Percutaneous cardiopulmonary bypass: application and indication for use. Ann Thorac Surg. 1989;47:121–3.PubMedCrossRef

26.

Vogel RA, Shawl FA, Tommasso CL, et al. Initial report of the national registry of elective cardiopulmonary bypass supported coronary angioplasty. J Am Coll Cardiol. 1990;15:23–9.PubMedCrossRef

27.

Schreiber TL, Kodali UR, O’Neill WW, et al. Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PTCA). Cathet Cardiovasc Diagn. 1998;45:115–9.PubMedCrossRef

28.

Cyrus T, Mathews SJ, Lasala JM, et al. Use of mechanical assist during high- risk PCI and STEMI with cardiogenic shock. Catheter Cardiovasc Interv. 2010;75:S1–6.PubMedCrossRef

29.

de Souza CF, de Souza BF, De Lima VC, et al. Percutaneous mechanical assistance for the failing heart. J Interv Cardiol. 2010;23:195–202.PubMedCrossRef

30.

Sjauw KD, Remmelink M, Baan JR, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol. 2008;51:1044–6.PubMedCrossRef

31.

Henriques JP, Remmelink M, Baan Jr J, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella^® Recover 2.5. Am J Cardiol. 2006;97:990–2.PubMedCrossRef

32.

Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella® 2.5 System in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;2:91–6.PubMedCrossRef

33.

Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584–8.PubMedCrossRef

34.

Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist device vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102–8.PubMedCrossRef

35.

Pulido JN, Park SJ, Charenjit S, et al. Percutaneous left ventricular assist devices: clinical uses, future applications and anesthetic considerations. J Cardiothorac Vasc Anesth. 2010;24:478–86.PubMedCrossRef

36.

Aragon J, Lee MS, Kar S, et al. Percutaneous left ventricular assist device: “TandemHeart^TM” for high-risk coronary intervention. Catheter Cardiovasc Interv. 2005;65:346–52.PubMedCrossRef

37.

Vranckx P, Meliga E, De Jaegere PP, et al. The TandemHeart™ percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. EuroIntervention. 2008;4:331–7.PubMedCrossRef

38.

Atiemo AD, Conte JV, Heldman AW. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv. 2006;68:78–82.PubMedCrossRef

39.

Prutkin JM, Strote JA, Stout KK. Percutaneous right ventricular assist device as support for cardiogenic shock due to right ventricular infarction. J Invasive Cardiol. 2008;20:E215–6.PubMed

40.

Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–83.PubMedCrossRef

41.

Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart™ percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469e1–4698.CrossRef

42.

Rajdev S, Krishnan P, Irani A, et al. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart™) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience. J Invasive Cardiol. 2008;20:67–72.PubMed

43.

Al-Husami W, Yturralde F, Mohanty G, et al. Single-center experience with the TandemHeart™ percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2008;20:319–22.PubMed

44.

Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431–8.PubMedCrossRef

45.

Schober A, Zercecke A. Chemokines in vascular remodeling. Thromb Haemost. 2007;97:730–7.PubMed

46.

Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100:967–78.PubMedCrossRef

47.

Korshunov VA, Schwartz SM, Berk BC. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov’s phenomenon. Arterioscler Thromb Vasc Biol. 2007;27:1722–8.PubMedCrossRef

48.

Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371–5.PubMedCrossRef

49.

Bond MG, Adams MR, Bullock BC. Complicating factors in evaluating coronary artery atherosclerosis. Artery. 1981;9:21–9.PubMed

50.

Bonthu S, Heistad DD, Chappel DA, et al. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 1997;17:2333–40.PubMedCrossRef

51.

Armstrong ML, Heistad DD, Marcus ML, et al. Structural and hemodynamic response of peripheral arteries of macque monkeys to atherogenic diet. Arteriosclerosis. 1985;5:336–46.PubMedCrossRef

52.

Courtman DW, Schwartz SM, Hart CE. Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass: extrinsic pathway inhibition eliminates luminal narrowing. Circ Res. 1998;82:996–1006.PubMedCrossRef

53.

Cote G, Tardif JC, Lesperance J, et al. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Probucol Study Group. Circulation. 1999;99:30–5.PubMedCrossRef

54.

Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful transluminal coronary angioplasty: serial angiographic follow-up of 229 consecutive patients. J Am Coll Cardiol. 1988;12:616–23.PubMedCrossRef

55.

Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: multivitamins and Probucol Study Group. N Engl J Med. 1997;337:365–72.PubMedCrossRef

56.

Korbling M, Estrov Z. Adult stem cells for tissue repair: a new therapeutic concept? N Engl J Med. 2003;349:570–82.PubMedCrossRef

57.

Ross JJ, Hong Z, Willenbring Z, et al. Cytokine-induced differentiation of multipotent adult progenitor cells Into functional smooth muscle cells. J Clin Invest. 2006;116:3139–49.PubMedCrossRef

58.

Shober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 2008;28:1950–9.CrossRef

59.

Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation. 2008;17:2131–41.CrossRef

60.

Hasdai D, Berger PB, Battler A, Holmes Jr DR, editors. Cardiogenic shock: diagnosis and treatment. Totowa: Humana Press; 2002.

Titel: Acute Catheter-Based Mechanical Circulatory Support
Auteurs: Gladwin S. Das, MD
Ganesh Raveendran, MD
Jason C. Schultz, MD
Uitgeverij: Springer US
Boek: Coronary Heart Disease
Print ISBN: 978-1-4614-1474-2

Elektronisch ISBN: 978-1-4614-1475-9

Copyright: 2012
DOI: https://doi.org/10.1007/978-1-4614-1475-9_25

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen